{{Rsnum
|rsid=10830956
|Gene=MIR194-2
|Chromosome=11
|position=92947847
|Orientation=plus
|GMAF=0.3522
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 47.7 | 47.7 | 4.6
| HCB | 18.2 | 65.9 | 15.9
| JPT | 24.4 | 44.4 | 31.1
| YRI | 34.9 | 38.1 | 27.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 18.2 | 65.9 | 15.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21386085
|Trait=None
|Title=A Bivariate Genome-Wide Approach to Metabolic Syndrome: STAMPEED Consortium
|RiskAllele=C
|Pval=5E-11
|OR=0.2000
|ORtxt=[0.14-0.26] unit decrease
|OA=1
}}{{PMID Auto
|PMID=19324940
|Title=G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans.
|OA=1
}}